Literature DB >> 22638780

Predictors for lymph node metastasis in T1 colorectal cancer.

J H Suh1, K S Han, B C Kim, C W Hong, D K Sohn, H J Chang, M J Kim, S C Park, J W Park, H S Choi, J H Oh.   

Abstract

BACKGROUND AND STUDY AIMS: It is critical that the risk of lymph node metastasis (LNM) is evaluated for determining the suitability of endoscopic resection for T1 colorectal cancer (CRC). Reported risk factors for LNM in completely resected T1 CRC are deep submucosal invasion, grade 3, angiolymphatic invasion, and budding. The aim of the present study was to identify the histopathologic factors associated with LNM in T1 CRC. PATIENTS AND METHODS: The study involved 435 patients with T1 CRC treated by endoscopic or surgical resection between January 2001 and April 2010 at the National Cancer Center, Korea. The 435 patients were classified into two groups - those undergoing surgical resection (n = 324) and those undergoing endoscopic resection (n = 111). In the surgically resected group, details regarding depth of submucosal invasion, angiolymphatic invasion, tumor grade, budding, and background adenoma (BGA) were evaluated with respect to presence or absence of LNM. In the endoscopically resected group, the results of follow-ups and additional salvage surgeries were studied.
RESULTS: In the surgically resected group, LNM was detected in 42 patients (13.0 %). Grade 3, angiolymphatic invasion, budding, and the absence of BGA were identified as factors associated with LNM in univariate and multivariate analyses (P < 0.05). Among the 50 patients in the endoscopically resected group with high risk, three were diagnosed as being LNM-positive during the follow-up period. There was no LNM in the endoscopically resected group with low risk.
CONCLUSIONS: Grade 3, angiolymphatic invasion, budding, and the absence of BGA are the risk factors that predict LNM in patients with T1 CRC. In cases where endoscopically resected T1 CRC has no risk factor, cautious follow-up could be recommended. However, if the tumor has any risk factor, additional surgical resection should be considered. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22638780     DOI: 10.1055/s-0031-1291665

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  35 in total

1.  Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group.

Authors:  Yuzuru Tamaru; Shiro Oka; Shinji Tanaka; Shinji Nagata; Yuko Hiraga; Toshio Kuwai; Akira Furudoi; Tadamasa Tamura; Masaki Kunihiro; Hideharu Okanobu; Koichi Nakadoi; Hiroyuki Kanao; Makoto Higashiyama; Koji Arihiro; Kazuya Kuraoka; Fumio Shimamoto; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2017-02-13       Impact factor: 7.527

2.  The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.

Authors:  Weixing Dai; Shaobo Mo; Wenqiang Xiang; Lingyu Han; Qingguo Li; Renjie Wang; Ye Xu; Guoxiang Cai
Journal:  Oncologist       Date:  2019-11-20

3.  Incomplete resection after macroscopic radical endoscopic resection of T1 colorectal cancer-should a paradigm-changing approach to address the risk be considered?

Authors:  Felix W Leung
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-29

4.  The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.

Authors:  Weixing Dai; Shaobo Mo; Wenqiang Xiang; Lingyu Han; Qingguo Li; Renjie Wang; Ye Xu; Guoxiang Cai
Journal:  Oncologist       Date:  2019-11-20

Review 5.  Update on Difficult Polypectomy Techniques.

Authors:  Saowanee Ngamruengphong; Heiko Pohl; Yamile Haito-Chavez; Mouen A Khashab
Journal:  Curr Gastroenterol Rep       Date:  2016-01

6.  Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.

Authors:  Beonghoon Sohn; Yoomin Kwon; Seung-Bum Ryoo; Inho Song; Yoon-Hye Kwon; Dong Woon Lee; Sang Hui Moon; Ji Won Park; Seung-Yong Jeong; Kyu Joo Park
Journal:  J Gastrointest Surg       Date:  2017-10-18       Impact factor: 3.452

7.  Evidence-based clinical practice guidelines for management of colorectal polyps.

Authors:  Shinji Tanaka; Yusuke Saitoh; Takahisa Matsuda; Masahiro Igarashi; Takayuki Matsumoto; Yasushi Iwao; Yasumoto Suzuki; Hiroshi Nishida; Toshiaki Watanabe; Tamotsu Sugai; Ken-Ichi Sugihara; Osamu Tsuruta; Ichiro Hirata; Nobuo Hiwatashi; Hiroshi Saito; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-07       Impact factor: 7.527

8.  A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer.

Authors:  Jun Yan; Fangqin Xue; Hongyuan Chen; Xiufeng Wu; Hui Zhang; Gang Chen; Jianping Lu; Lisheng Cai; Gao Xiang; Zhenwei Deng; Yu Zheng; Xiaoling Zheng; Guoxin Li
Journal:  Surg Endosc       Date:  2014-06-17       Impact factor: 4.584

9.  Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery.

Authors:  Zheng Lou; Rong-Gui Meng; Wei Zhang; En-Da Yu; Chuan-Gang Fu
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

10.  L1CAM is involved in lymph node metastasis via ERK1/2 signaling in colorectal cancer.

Authors:  Qing-Xia Fang; Xiao-Chun Zheng; Hua-Jun Zhao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.